JPWO2022058445A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2022058445A5 JPWO2022058445A5 JP2023517243A JP2023517243A JPWO2022058445A5 JP WO2022058445 A5 JPWO2022058445 A5 JP WO2022058445A5 JP 2023517243 A JP2023517243 A JP 2023517243A JP 2023517243 A JP2023517243 A JP 2023517243A JP WO2022058445 A5 JPWO2022058445 A5 JP WO2022058445A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- bispecific antibody
- seq
- subject
- gprc5dxcd3 bispecific
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063079294P | 2020-09-16 | 2020-09-16 | |
| US63/079,294 | 2020-09-16 | ||
| US202063116549P | 2020-11-20 | 2020-11-20 | |
| US63/116,549 | 2020-11-20 | ||
| US202163187888P | 2021-05-12 | 2021-05-12 | |
| US63/187,888 | 2021-05-12 | ||
| PCT/EP2021/075523 WO2022058445A1 (en) | 2020-09-16 | 2021-09-16 | Methods for treating multiple myeloma |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023542124A JP2023542124A (ja) | 2023-10-05 |
| JPWO2022058445A5 true JPWO2022058445A5 (enExample) | 2024-09-25 |
Family
ID=77924410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023517243A Pending JP2023542124A (ja) | 2020-09-16 | 2021-09-16 | 多発性骨髄腫を治療するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20220177584A1 (enExample) |
| EP (1) | EP4213945A1 (enExample) |
| JP (1) | JP2023542124A (enExample) |
| KR (1) | KR20230069959A (enExample) |
| CN (1) | CN116322769A (enExample) |
| AU (1) | AU2021346129A1 (enExample) |
| BR (1) | BR112023004830A2 (enExample) |
| CA (1) | CA3194796A1 (enExample) |
| IL (1) | IL301361A (enExample) |
| MX (1) | MX2023003086A (enExample) |
| WO (1) | WO2022058445A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI781108B (zh) | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| JP2025532460A (ja) | 2022-09-09 | 2025-10-01 | ベイジン マブワークス バイオテック カンパニー リミテッド | 多重特異性抗体結合ｂｃｍａ、ｇｐｒｃ５ｄ、及びｃｄ３、及びその使用 |
| CN117924485A (zh) * | 2022-10-25 | 2024-04-26 | 上海祥耀生物科技有限责任公司 | 一种抗gprc5d的多特异性抗体 |
| CN120916780A (zh) * | 2023-02-28 | 2025-11-07 | 詹森生物科技公司 | 包含双特异性gprc5d/cd3抗体的组合物 |
| WO2024220682A1 (en) * | 2023-04-19 | 2024-10-24 | Janssen Biotech, Inc. | Methods for treating multiple myeloma |
| KR20260020402A (ko) | 2023-06-01 | 2026-02-11 | 얀센 바이오테크 인코포레이티드 | 다발성 골수종의 치료 방법 |
| WO2025094085A1 (en) | 2023-10-31 | 2025-05-08 | Janssen Biotech, Inc. | Combination regimens for treating multiple myeloma |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1988001649A1 (en) | 1986-09-02 | 1988-03-10 | Genex Corporation | Single polypeptide chain binding molecules |
| GB9015198D0 (en) | 1990-07-10 | 1990-08-29 | Brien Caroline J O | Binding substance |
| DK0672142T3 (da) | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| AUPO591797A0 (en) | 1997-03-27 | 1997-04-24 | Commonwealth Scientific And Industrial Research Organisation | High avidity polyvalent and polyspecific reagents |
| ES2564523T3 (es) | 2007-12-19 | 2016-03-23 | Janssen Biotech, Inc. | Diseño y generación de bibliotecas de presentación en fago por pIX de novo humanas mediante fusión con pIX o pVII, vectores, anticuerpos y métodos |
| TWI781108B (zh) * | 2016-07-20 | 2022-10-21 | 比利時商健生藥品公司 | 抗ｇｐｒｃ５ｄ抗體、結合ｇｐｒｃ５ｄ與ｃｄ３之雙特異性抗原結合分子及其用途 |
| KR20200041834A (ko) * | 2017-06-01 | 2020-04-22 | 젠코어 인코포레이티드 | Cd123 및 cd3에 결합하는 이중특이성 항체 |
| CA3100157A1 (en) * | 2018-05-16 | 2019-11-21 | Janssen Biotech, Inc. | Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics |
| SG11202112491WA (en) * | 2019-07-31 | 2021-12-30 | Hoffmann La Roche | Antibodies binding to gprc5d |
-
2021
- 2021-09-16 IL IL301361A patent/IL301361A/en unknown
- 2021-09-16 US US17/477,435 patent/US20220177584A1/en active Pending
- 2021-09-16 BR BR112023004830A patent/BR112023004830A2/pt unknown
- 2021-09-16 CN CN202180063247.6A patent/CN116322769A/zh active Pending
- 2021-09-16 CA CA3194796A patent/CA3194796A1/en active Pending
- 2021-09-16 WO PCT/EP2021/075523 patent/WO2022058445A1/en not_active Ceased
- 2021-09-16 KR KR1020237012190A patent/KR20230069959A/ko active Pending
- 2021-09-16 MX MX2023003086A patent/MX2023003086A/es unknown
- 2021-09-16 JP JP2023517243A patent/JP2023542124A/ja active Pending
- 2021-09-16 EP EP21778070.9A patent/EP4213945A1/en active Pending
- 2021-09-16 AU AU2021346129A patent/AU2021346129A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPWO2019220368A5 (enExample) | ||
| IL278667B1 (en) | Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics | |
| JP2018520101A5 (enExample) | ||
| JP2022185004A5 (enExample) | ||
| US11591406B2 (en) | Treatment for multiple myeloma (MM) | |
| RU2020119365A (ru) | Химерный антигенный рецептор, нацеливающийся на всма, химерный антигенный рецептор, нацеливающийся на cd19, и средства комбинированной терапии | |
| Jelinek et al. | Monoclonal antibodies—a new era in the treatment of multiple myeloma | |
| JP2011507932A5 (enExample) | ||
| EP2192921A1 (de) | Intraoperative trifunktionale antikörper-applikation zur prophylaxe intraperitonealer tumorzelldissemination | |
| JP2015500822A5 (enExample) | ||
| RU2010130977A (ru) | Иммуноконъюгаты, направленные на cd138, и их применение | |
| US20240307541A1 (en) | Methods for local and systemic treatment of cancers, tumors and tumor cells | |
| JPWO2022058445A5 (enExample) | ||
| CA3159534A1 (en) | Anti-cd19 therapy in combination with lenalidomide for the treatment of leukemia or lymphoma | |
| JPWO2023081705A5 (enExample) | ||
| US20210023099A1 (en) | Combination therapy with a bet inhibitor and a proteasome inhibitor | |
| JPWO2021113701A5 (enExample) | ||
| US20240360215A1 (en) | Anti-cd19 antibody in the treatment of cns lymphoma | |
| DE4312916C2 (de) | Arzneimittel zur Behandlung von Immunreaktionen | |
| JPWO2021090272A5 (enExample) | ||
| JPWO2023081704A5 (enExample) | ||
| NZ769788B2 (en) | Methods of treating cancers and enhancing efficacy of t cell redirecting therapeutics | |
| JPWO2020102375A5 (enExample) | ||
| RU2022129376A (ru) | Комбинированный лекарственный препарат для лечения рака почек | |
| JPWO2023177772A5 (enExample) |